Aurobindo Pharma's biosimilar for breast cancer recommended for EU approval, demonstrating similarity to Herceptin.

By using a compound derived from a Himalayan fungus and used for centuries in Chinese medicine as a jumping off point, ...

Having Breast Cancer Without Knowing: Silent Signs You Shouldn’t Ignore. Introduction: How long can you have breast cancer ...

Michael Wolff was at the "edge of a cliff" when he was diagnosed with a cancer that affects less than 300 patients a year in the U.S.

If the European Commission approves this treatment, it'll be the first HER2-targeted agent for HER2-positive biliary tract cancer available to patients in the EU.

Just over a month after laying off staff to focus on its lead cancer candidate, ALX Oncology announced that the asset ...

In a review of 182 cancer studies, authors failed to report outcome data by sex in 90% of cases, even though men develop ...

ZW171 exhibits strong anti-tumor activity in patient derived xenograft (PDX) models of NSCLC and pancreatic cancer, and in ex-vivo patient-derived ovarian cancer organoids with endogenous ...

Liver cancer poses significant challenges due to its complex causes and resistance to conventional treatments, highlighting the need for innovative ...

Fingrut, MD, assistant professor of stem cell transplantation and cellular therapy at The University of Texas MD Anderson Cancer Center. Stem cell donations can be done in different ways ...

ALX Oncology (ALXO) announced topline data from its Phase 2 ASPEN-03 and ASPEN-04 clinical trials. The company’s investigational CD47-blocker ...

AACR conference chairs Lillian L. Siu, MD, and Matthew Vander Heiden, MD, PhD, share their perspectives on the event with GEN ...